Insufficient scRNA-seq data for expression of GAL at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
intestine | 88% | 418.33 | 847 / 966 | 73% | 28.53 | 383 / 527 |
prostate | 49% | 157.06 | 119 / 245 | 76% | 8.97 | 383 / 502 |
stomach | 52% | 311.06 | 185 / 359 | 67% | 25.47 | 192 / 286 |
esophagus | 53% | 197.07 | 764 / 1445 | 59% | 25.00 | 108 / 183 |
eye | 0% | 0 | 0 / 0 | 90% | 16.34 | 72 / 80 |
breast | 47% | 100.01 | 217 / 459 | 35% | 8.83 | 389 / 1118 |
skin | 54% | 542.99 | 980 / 1809 | 26% | 11.50 | 125 / 472 |
pancreas | 28% | 26.94 | 92 / 328 | 43% | 5.25 | 77 / 178 |
bladder | 19% | 19.05 | 4 / 21 | 42% | 16.87 | 213 / 504 |
lung | 10% | 10.95 | 57 / 578 | 46% | 13.09 | 526 / 1155 |
adrenal gland | 9% | 18.90 | 23 / 258 | 41% | 123.08 | 95 / 230 |
ovary | 2% | 1.40 | 3 / 180 | 46% | 16.63 | 199 / 430 |
brain | 27% | 270.31 | 709 / 2642 | 20% | 2.51 | 139 / 705 |
adipose | 44% | 97.70 | 534 / 1204 | 0% | 0 | 0 / 0 |
uterus | 4% | 4.34 | 6 / 170 | 36% | 7.43 | 163 / 459 |
tonsil | 0% | 0 | 0 / 0 | 27% | 5.69 | 12 / 45 |
kidney | 16% | 39.08 | 14 / 89 | 3% | 0.38 | 31 / 901 |
liver | 4% | 3.51 | 8 / 226 | 7% | 0.93 | 28 / 406 |
thymus | 7% | 9.39 | 43 / 653 | 2% | 0.24 | 12 / 605 |
blood vessel | 8% | 12.15 | 103 / 1335 | 0% | 0 | 0 / 0 |
heart | 7% | 11.49 | 63 / 861 | 0% | 0 | 0 / 0 |
muscle | 3% | 5.90 | 27 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 3% | 3.00 | 26 / 929 | 0% | 0 | 0 / 0 |
spleen | 2% | 6.15 | 4 / 241 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0007218 | Biological process | neuropeptide signaling pathway |
GO_0043627 | Biological process | response to estrogen |
GO_0007631 | Biological process | feeding behavior |
GO_0035902 | Biological process | response to immobilization stress |
GO_0051795 | Biological process | positive regulation of timing of catagen |
GO_0032868 | Biological process | response to insulin |
GO_0019933 | Biological process | cAMP-mediated signaling |
GO_0010737 | Biological process | protein kinase A signaling |
GO_0050672 | Biological process | negative regulation of lymphocyte proliferation |
GO_0031943 | Biological process | regulation of glucocorticoid metabolic process |
GO_1902608 | Biological process | positive regulation of large conductance calcium-activated potassium channel activity |
GO_0030073 | Biological process | insulin secretion |
GO_0009410 | Biological process | response to xenobiotic stimulus |
GO_0043065 | Biological process | positive regulation of apoptotic process |
GO_0051464 | Biological process | positive regulation of cortisol secretion |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0005615 | Cellular component | extracellular space |
GO_0005576 | Cellular component | extracellular region |
GO_0043025 | Cellular component | neuronal cell body |
GO_0030141 | Cellular component | secretory granule |
GO_0031763 | Molecular function | galanin receptor binding |
GO_0031766 | Molecular function | type 3 galanin receptor binding |
GO_0031764 | Molecular function | type 1 galanin receptor binding |
GO_0004966 | Molecular function | galanin receptor activity |
GO_0031765 | Molecular function | type 2 galanin receptor binding |
GO_0005515 | Molecular function | protein binding |
GO_0005184 | Molecular function | neuropeptide hormone activity |
Gene name | GAL |
Protein name | Galanin peptides [Cleaved into: Galanin; Galanin message-associated peptide (GMAP)] |
Synonyms | GALN GAL1 GLNN |
Description | FUNCTION: Endocrine hormone of the central and peripheral nervous systems that binds and activates the G protein-coupled receptors GALR1, GALR2, and GALR3. This small neuropeptide may regulate diverse physiologic functions including contraction of smooth muscle of the gastrointestinal and genitourinary tract, growth hormone and insulin release and adrenal secretion. . |
Accessions | ENST00000265643.4 P22466 |